Clinical Trial Detail

NCT ID NCT03226418
Title Cytarabine, Idarubicin, Liposome-encapsulated Daunorubicin-Cytarabine or Decitabine in Treating Older Patients With Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska
Indications

acute myeloid leukemia

Therapies

Cytarabine

Decitabine + Venetoclax

Azacitidine + Venetoclax

CPX-351

Cytarabine + Idarubicin

Azacitidine + Glasdegib

Decitabine + Glasdegib

Age Groups: senior adult

No variant requirements are available.